These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 19227153)
41. [Drug resistance of Mycobacterium leprae]. Pattyn SR Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466 [No Abstract] [Full Text] [Related]
42. China. Leprosy's last stand--or early days of a war of attrition? Stone R Science; 2010 Feb; 327(5968):939. PubMed ID: 20167759 [No Abstract] [Full Text] [Related]
43. Impact of integration of NLEP into PHC system in Madurai district, Tamil Nadu, and status of integration of leprosy patients into the community. Elango S Indian J Lepr; 2003; 75(4):347-54. PubMed ID: 15242273 [TBL] [Abstract][Full Text] [Related]
44. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy. Pattyn S; Grillone S Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986 [No Abstract] [Full Text] [Related]
45. Regarding Brasil, et al.'s adverse effects in leprosy's WHO/MDT and paramedic's role in leprosy control program. Cunha Mda G; Schettini AP; Pereira ES; Pedrosa VL; Cruz RC; Sadahiro M Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):257-9. PubMed ID: 9251600 [No Abstract] [Full Text] [Related]
47. Author's reply. Sengupta U Indian J Dermatol Venereol Leprol; 2018; 84(4):445. PubMed ID: 29893300 [No Abstract] [Full Text] [Related]
48. [Eradication of leprosy and public health. Vaccination and multidrug therapy]. Janaszek W Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583 [TBL] [Abstract][Full Text] [Related]
49. Leprosy in Malaysia. Jayalakshmi P Malays J Pathol; 1994 Jun; 16(1):7-9. PubMed ID: 16329568 [TBL] [Abstract][Full Text] [Related]
51. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam. Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655 [TBL] [Abstract][Full Text] [Related]
52. Leprosy: too complex a disease for a simple elimination paradigm. Lockwood DN; Suneetha S Bull World Health Organ; 2005 Mar; 83(3):230-5. PubMed ID: 15798849 [TBL] [Abstract][Full Text] [Related]
54. Primary dapsone resistant Mycobacterium leprae in a non endemic country. Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326 [No Abstract] [Full Text] [Related]
55. Leprosy in the WHO African region. Daumerie D World Health Stat Q; 1991; 44(1):16-22. PubMed ID: 2068820 [TBL] [Abstract][Full Text] [Related]
56. National Leprosy Eradication Programme, India. National Action Plan for 2006-07. Central Leprosy Division of the Directorate General of Health Services Indian J Lepr; 2006; 78(1):48-50. PubMed ID: 16646283 [No Abstract] [Full Text] [Related]
57. [Research in developing countries: will leprosy vaccine be produced in Nepal?]. Kurlberg G Nord Med; 1990; 105(12):338-9. PubMed ID: 2270200 [TBL] [Abstract][Full Text] [Related]
58. Single-dose treatment for paucibacillary leprosy; clinical problems and management. Pai VV; Bulchand HO; Revankar CR; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414 [No Abstract] [Full Text] [Related]
60. An appraisal of medical research in the treatment and control of leprosy. Rees RJ Lepr India; 1982 Oct; 54(4):783-800. PubMed ID: 6763969 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]